Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Boehringer, Eli Lilly get FDA fast track status for Jardiance to treat chronic kidney disease
Boehringer, Eli Lilly get FDA fast track status for Jardiance to treat chronic kidney disease
Boehringer Ingelheim and Eli Lilly have secured fast track status from the US Food and Drug Administration (FDA) for the investigation of Jardiance (empagliflozin) to treat chronic kid...
After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work
After Kymera's raise, Nurix nabs $120M as it too hones in on clinical work
Sanofi- and Gilead Sciences-backed Nurix Therapeutics is following suit with rival biotech Kymera in raising a major cash haul for its protein modulation R&D work.
Pfizer, Merck KGaA’s Bavencio skewered by Javelin in head and neck cancer
Pfizer, Merck KGaA’s Bavencio skewered by Javelin in head and neck cancer
Pfizer and Merck KGaA’s Bavencio threw another Javelin but missed their target in head and neck cancer.
Venclyxto gains approval in Europe
Venclyxto gains approval in Europe
The European Commission has approved Venclyxto (venetoclax) in combination with Gazyvaro (obinutuzumab) for the treatment of adult patients with previously untreated chronic lymphocyti...
New Coronavirus Test 10 Times Faster Is FDA Approved
New Coronavirus Test 10 Times Faster Is FDA Approved
U.
Look for novel coronavirus treatments first, experts say, and vaccines are farther off than you think
Look for novel coronavirus treatments first, experts say, and vaccines are farther off than you think
What's the outlook for really fending off the novel coronavirus? Small molecule drugs and other therapeutics will obviously beat vaccines to market, and Gilead's remdesivir, if effective, coul...
Biogen signs on to manufacture clinical supplies for Vir's COVID-19 antibodies
Biogen signs on to manufacture clinical supplies for Vir's COVID-19 antibodies
Biopharma companies across the globe are scrambling to address the novel coronavirus outbreak, which was declared a pandemic on Wednesday.
WHO declares the coronavirus outbreak a pandemic
WHO declares the coronavirus outbreak a pandemic
The World Health Organization on Wednesday declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging what has seemed clear for some time — the virus will likely spread to all cou...
Chinese researchers find key neuron of stress coping strategies
Chinese researchers find key neuron of stress coping strategies
BEIJING, March 11 (Xinhua) -- To "fight or flight" in stressful conditions, is a well-known scientific question.
Bora Pharmaceuticals to acquire GSK Mississauga-based Facility
Bora Pharmaceuticals to acquire GSK Mississauga-based Facility
Mississauga, ON, March 10, 2020 – Bora Pharmaceuticals Co.
Gates-funded project to offer home-testing kits for coronavirus
Gates-funded project to offer home-testing kits for coronavirus
SAN FRANCISCO, March 10 (Xinhua) -- A project funded by Bill Gates and his foundation will soon begin to offer home-testing kits that allow people who fear they may be infected with the corona...
FDA Approves New Treatment for Adults with Cushing’s Disease
FDA Approves New Treatment for Adults with Cushing’s Disease
The U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand